| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.27 | 0.1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |